Clinical Investigators Who Tested
Sunrise Product Held Its Shares

By

Danielle Sessa Staff Reporter of The Wall Street Journal

Updated July 21, 1999 2:11 a.m. ET

Sunrise Technologies International Inc. will go before a U.S. Food and Drug Administration advisory panel Thursday, hoping to get a step closer to having its laser treatment for farsightedness approved.

The company will present evidence from clinical trials. But one thing the members of the panel won't necessarily hear is that at least seven of the 11 clinical investigators who performed the trials of the vision-correction system own...